Home › Ulcerative Colitis › Washington › Tacoma
Pag-aaral pangklinika para sa Ulcerative Colitis sa Tacoma, WA
14 pag-aaral para sa Ulcerative Colitis ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Tacoma (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Nagre-recruitPhase 2
- Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
- GI Alliance Tacoma, Tacoma
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Nagre-recruitPhase 3
- Washington Gastroenterology - Tacoma, Tacoma
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Nagre-recruitPhase 2/3
- MultiCare Health System, Tacoma
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 2
- Washington Gastroenterology - Tacoma, Tacoma
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Nagre-recruitPhase 4
- Washington Gastroenterology- GIA, Tacoma
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Nagre-recruitPhase 3
- Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
- GI Alliance Tacoma, Tacoma
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Nagre-recruitPhase 2
- Site 019, Tacoma
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Nagre-recruitPhase 2
- Digestive Health Specialists, Tacoma
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Nagre-recruitPhase 3
- MultiCare Institute for Research & Innovation, Tacoma
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Nagre-recruitObservasyonal na pag-aaral
- Washington Gastroenterology, Tacoma
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Nagre-recruitPhase 3
- Multicare Health System Institute for Research and Innovation, Tacoma
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Nagre-recruitPhase 2
- Mirador Therapeutics Selected Site, Tacoma
Pag-aaral para sa Ulcerative Colitis sa ibang lungsod
- New York City, NY24 pag-aaral
- Miami, FL22 pag-aaral
- Orlando, FL22 pag-aaral
- Houston, TX17 pag-aaral
- San Antonio, TX16 pag-aaral
- San Diego, CA15 pag-aaral
- Chicago, IL15 pag-aaral
- Colorado Springs, CO14 pag-aaral
- Tyler, TX13 pag-aaral
- Los Angeles, CA13 pag-aaral
- St. Louis, MO13 pag-aaral
- Washington, DC12 pag-aaral
Iba pang pag-aaral sa Tacoma
- Non-Small Cell Lung Cancer20 pag-aaral
- Kanser sa Suso18 pag-aaral
- Multiple Myeloma13 pag-aaral
- Crohn's Disease11 pag-aaral
- Kanser sa Prostate11 pag-aaral
- Metastatic Cancer9 pag-aaral
- Colorectal Cancer9 pag-aaral
- Melanoma7 pag-aaral
- Kanser sa Ovary7 pag-aaral
- Kanser (lahat ng uri)6 pag-aaral
- Kanser sa Esophagus6 pag-aaral
- Kanser sa Tiyan6 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Set 29, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.